Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.
Can AI facilitate a grand comeback for medicines sourced from Mother Nature?
We interview Mary Lavin, President of Sartorius North America, about her career.
Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.
Advanz Pharma is fined for substantially hiking the price of a generic drug.
How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.
The EMA releases its annual report highlighting its achievements throughout 2020.
We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.
How can pharma make the most of digital technologies?
GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
X2: Researchers United
Autoinjectors: Through Thick and Thin
Staying on the Track to Eradication